Equities research analysts forecast that Cooper Companies Inc (NYSE:COO) will report $581.91 million in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Cooper Companies’ earnings, with estimates ranging from $569.50 million to $591.10 million. Cooper Companies reported sales of $499.10 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 16.6%. The business is expected to announce its next earnings results after the market closes on Thursday, March 8th.
On average, analysts expect that Cooper Companies will report full-year sales of $581.91 million for the current fiscal year, with estimates ranging from $2.49 billion to $2.66 billion. For the next year, analysts anticipate that the business will report sales of $2.68 billion per share, with estimates ranging from $2.57 billion to $2.82 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover Cooper Companies.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, beating analysts’ consensus estimates of $2.64 by $0.01. The firm had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.28 earnings per share.
In other news, Director Stanley Md Zinberg sold 5,000 shares of the stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $224.66, for a total value of $1,123,300.00. Following the sale, the director now directly owns 6,090 shares of the company’s stock, valued at $1,368,179.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Allan E. Rubenstein sold 6,450 shares of the stock in a transaction on Friday, January 12th. The stock was sold at an average price of $228.79, for a total value of $1,475,695.50. Following the completion of the sale, the director now directly owns 8,628 shares in the company, valued at $1,974,000.12. The disclosure for this sale can be found here. Over the last three months, insiders sold 54,385 shares of company stock worth $12,289,463. Insiders own 1.60% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in COO. Advisory Services Network LLC grew its stake in shares of Cooper Companies by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after acquiring an additional 107 shares during the last quarter. BB&T Investment Services Inc. grew its stake in shares of Cooper Companies by 71.0% in the fourth quarter. BB&T Investment Services Inc. now owns 542 shares of the medical device company’s stock worth $119,000 after acquiring an additional 225 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Cooper Companies in the third quarter worth $163,000. Virtue Capital Management LLC purchased a new stake in shares of Cooper Companies during the fourth quarter valued at $195,000. Finally, FNY Managed Accounts LLC purchased a new stake in shares of Cooper Companies during the fourth quarter valued at $217,000. 96.27% of the stock is currently owned by hedge funds and other institutional investors.
Cooper Companies (NYSE:COO) opened at $232.47 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. The company has a market capitalization of $11,398.94, a P/E ratio of 30.91, a P/E/G ratio of 1.87 and a beta of 0.57. Cooper Companies has a twelve month low of $189.41 and a twelve month high of $256.39.
The business also recently announced a semiannual dividend, which was paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd were paid a $0.03 dividend. The ex-dividend date of this dividend was Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s dividend payout ratio is currently 0.80%.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.